» Go to news main
Molly Appeal paves the way to precision cancer treatment
Posted by Melanie Jollymore on
November 24, 2017
in
News
2017 Molly Appeal lead researchers (left to right) Wenda Greer, Zhaolin Xu and Paola Marignani. (Group photos by Danny Abriel; additional photos courtesy Dalhousie Medical Research Foundation)
A group of Dalhousie Medical School researchers is spearheading a new initiative to develop personalized cancer treatments, with support from Dalhousie Medical Research Foundation’s 2017-18 Molly Appeal.
“Every person’s cancer is as unique as their fingerprints,” says Dr. Paola Marignani, an internationally known cancer researcher and professor in Dalhousie’s Department of Biochemistry & Molecular Biology who’s leading this year’s Molly Appeal research initiative.
Read more on Dal News.
Recent News
- Part of the plan: On‑campus rapid testing provides extra layer of protection at Dal
- Global Health Office holds virtual year‑end celebration to commemorate its community partners
- Alumni achievements: Meet Dalhousie’s 2021 Aurum Award winners
- Students build knowledge‑mobilization skills in partnership with national children’s pain management network
- Grad Profiles ‑ Class of 2021 ready for what comes next: Perseverance on the path to graduation
- “All hands on deck” hits a whole new level: Learners and staff pitch in to process COVID backlog, stay ahead of third wave
- Dal Study Shows Importance of Physical activity and Social Connection for Kids during COVID‑19 Lockdowns
- Dal prof receives Governor General’s Innovation Award for 3D printed devices that improve cancer treatment